Home/Filings/4/0000950170-24-112230
4//SEC Filing

Tattoli Mark Damian 4

Accession 0000950170-24-112230

CIK 0001958086other

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 2:13 PM ET

Size

9.7 KB

Accession

0000950170-24-112230

Insider Transaction Report

Form 4
Period: 2024-10-01
Tattoli Mark Damian
SVP, Gen Counsel & Secretary
Transactions
  • Tax Payment

    Common Stock

    2024-10-01$19.21/sh276$5,30211,295.621 total
  • Exercise/Conversion

    Restricted Shares

    2024-10-017002,850 total
    Common Stock (700 underlying)
  • Exercise/Conversion

    Common Stock

    2024-10-01+70011,571.621 total
Holdings
  • Common Stock

    (indirect: 401 (k) Plan)
    1,694.842
  • Common Stock

    (indirect: Custodial account)
    20
Footnotes (2)
  • [F1]The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date.
  • [F2]Multiple restricted share grants are included in this total.

Documents

1 file

Issuer

Core Laboratories Inc. /DE/

CIK 0001958086

Entity typeother

Related Parties

1
  • filerCIK 0001872069

Filing Metadata

Form type
4
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 2:13 PM ET
Size
9.7 KB